stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. LSTA
    stockgist
    HomeTop MoversCompaniesConcepts
    LSTA logo

    Lisata Therapeutics, Inc.

    LSTA
    NASDAQ
    Healthcare
    Biotechnology
    Basking Ridge, NJ, US26 employeeslisata.com
    $5.01
    +0.01(0.10%)

    Mkt Cap $45M

    $1.86
    $5.04

    52-Week Range

    At a Glance

    AI-generated

    Lisata Therapeutics, Inc.

    Revenue breakdown: Reportable Segment (100%).

    8-K
    Lisata Therapeutics and Kuva Labs agreed to extend the deadline to commence a tender offer under their merger agreement from April 3, 2026, to April 13, 2026.

    $45M

    Market Cap

    $176.8K

    Revenue

    -$17M

    Net Income

    Employees26
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Reportable Segment100%($1M)
    Activity

    What Changed Recently

    Material Agreement
    Mar 8, 2026

    Entry into a Material Definitive Agreement. Agreement and Plan of Merger On March 6, 2026, Lisata Therapeutics, Inc., a Delaware corporation (the “Company” or “

    Material Agreement
    Feb 26, 2026

    Entry into a Material Definitive Agreement. Reference is made to the binding term sheet (the “Term Sheet”), dated as of January 20, 2026, by and between Lisata

    Material Agreement
    Jan 20, 2026

    Entry into a Material Definitive Agreement. Term Sheet On January 20, 2026, Lisata Therapeutics, Inc., a Delaware corporation (the “ Company ” or “ Lisata ”), e

    Other Event
    Apr 1, 2026

    | Other Events | |---|---| On April 2, 2026, Lisata Therapeutics, Inc. (the “Company” or “Lisata”) and Kuva Labs Inc., a Delaware corporation (“Parent”), togeth

    Other Event
    Jan 26, 2026

    Other Events. On January 23, 2026, Lisata Therapeutics, Inc. (the “Company”) and Qilu Pharmaceutical Co., Ltd. (“Qilu”) entered into a Mutual Termination Agreem

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    XCURExicure, Inc.$4.22+0.96%$27M-3.0
    PASGPassage Bio, Inc.$8.18+4.20%$26M-0.5
    ENLVEnlivex Therapeutics Ltd.$0.98+1.78%$24M-2.1
    KLTOKlotho Neurosciences, Inc...$0.38-7.10%$20M—
    PTHSPelthos Therapeutics Inc.$20.40-4.23%$13M—
    NCNANuCana plc$1.66+7.47%$10M-0.1
    CLGNCollPlant Biotechnologies...$0.49-8.20%$6M-0.6
    MTVAMetaVia Inc.$1.26+0.80%$3M-0.2
    Analyst View
    Company Profile
    CIK0000320017
    ISINUS1280583022
    CUSIP128058302
    Phone908 842 0100
    Address110 Allen Road, Basking Ridge, NJ, 07920, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice